点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 报告摘要 事件： 近日，工业和信息化部等七部委发布《关于推动脑机接口产业创新发展的实施意见》（下文简称《实施意 见》），意见指出到2027年实现电极、芯片、整机国际先进水平，打造2-3个产业发展集聚区，开拓一批新场 景、新模式、新业态；到2030年培育2-3家全球领军企业，构建具有竞争力的产业生态，综合实力迈入世界前 列。 点评： 《实施意见》聚焦五大重点任务、三个重点工程，有望加速脑机接口产业发展 《实施意见》提出的五大重点任务包括：加强基础软硬件攻关、打造高性能产品、推动技术成果应用、壮大创 新主体和提升产业支撑能力；三个重点工程包括：核心软硬件强基工程、整机精品工程和应用拓展工程；配套 的保障措施包括：强化统筹协调、加强政策支持和 ...

Investment Rating - The report maintains an "Increase" rating for the companies involved in the brain-computer interface (BCI) industry, specifically recommending companies like Weisi Medical and Xiangyu Medical [5]. Core Insights - The recent "Implementation Opinions" issued by the Ministry of Industry and Information Technology and other ministries focus on five key tasks and three major projects aimed at accelerating the development of the BCI industry, with goals set for 2027 and 2030 [1][2]. - By 2027, the report anticipates achieving international advanced levels in electrodes, chips, and complete machines, as well as establishing 2-3 industrial development clusters [1]. - By 2030, the aim is to cultivate 2-3 global leading enterprises and build a competitive industrial ecosystem [1]. Summary by Sections Key Tasks and Projects - The five key tasks outlined include strengthening foundational software and hardware, creating high-performance products, promoting the application of technological achievements, expanding innovative entities, and enhancing industrial support capabilities [2]. - The three major projects consist of core software and hardware foundational projects, high-quality complete machine projects, and application expansion projects [2]. Local Action Plans - Local governments, such as Beijing and Shanghai, have introduced action plans to develop the BCI industry, with Beijing aiming to form an initial industrial ecosystem by 2030 and Shanghai targeting the completion of over five invasive and semi-invasive BCI products by 2027 [3]. - Sichuan Province plans to cultivate 10 leading enterprises and 200 innovative SMEs by 2030, with a target of performing 3,000 invasive BCI surgeries annually [3]. Product Development and Clinical Trials - The report notes that non-invasive BCI products are progressing rapidly, with several companies expected to receive approvals for their products in the second half of the year [4]. - Companies like Brain Tiger Technology and Ladder Medical are leading in the clinical trial progress for invasive and semi-invasive BCI products [4]. Investment Recommendations - The report recommends investing in companies that have early layouts in BCI products, such as Xiangyu Medical and Weisi Medical, while also suggesting attention to other companies like Chengyitong and Aipeng Medical [4].

Core Viewpoint - The brain-computer interface (BCI) sector is experiencing significant growth, driven by advancements from companies like Neuralink and recent breakthroughs in China, indicating a potential commercialization of BCI technology in the near future [2][4][5]. Group 1: Neuralink Developments - Neuralink has showcased its latest research and product development, with 7 participants currently using the device for an average of 50 hours per week, peaking over 100 hours [2]. - The company plans to implant devices in the speech cortex by the end of 2025 to decode silent speech from brain signals, and aims to increase electrode channels to 3,000 by 2026 to explore restoring vision [2][3]. - By 2028, Neuralink anticipates implanting over 25,000 electrodes to address mental health issues and explore integration with AI, potentially allowing humans to control robots directly [3]. Group 2: Market Potential and Growth - The global BCI market is projected to grow from $2.62 billion in 2024 to approximately $12.4 billion by 2034, with a compound annual growth rate (CAGR) of 17.35% [4]. - The BCI technology is recognized as one of the most disruptive technologies of the 21st century, with expectations for a surge in medical product applications over the next 5 to 10 years [4]. Group 3: Domestic Developments in China - Recent successful trials in China, including the first invasive BCI-assisted rehabilitation for a stroke patient, highlight the rapid advancement of BCI technology towards commercialization [4]. - The "Beijing Brain Institute" has developed a flexible, high-throughput, semi-invasive BCI system that has entered clinical trials, marking significant progress in the field [4]. Group 4: Industry Insights - The domestic BCI industry is benefiting from technological breakthroughs and supportive government policies, which are expected to accelerate the commercialization process [5]. - BCI products are categorized into non-invasive and invasive types, with non-invasive products leading in commercialization, while invasive products are still in clinical research stages [6]. - Despite the promising outlook, the BCI industry faces challenges related to safety, regulatory approval, and the need for foundational research [6][7].

Group 1: Industry Overview - Brain-computer interface (BCI) technology is advancing rapidly due to breakthroughs in artificial intelligence, neuroscience, and sensing technologies [1] - The Sichuan Provincial Economic and Information Technology Department has launched a plan to develop BCI products, aiming to complete the R&D of 3 invasive and 5 non-invasive BCI products by 2027 [1] - The plan also targets to serve over 50,000 medical patients annually by 2027 and to establish Sichuan as a national leader in BCI and human-computer interaction by 2030 [1] Group 2: Non-Invasive BCI Applications - Non-invasive BCI technology is expected to significantly improve the early diagnosis and treatment efficiency of Alzheimer's disease [2] - The technology aims to manage chronic diseases in the elderly through early screening and outpatient rehabilitation [2] - A project named "Swan Lake" has been developed for community-based early screening and non-drug interventions for mild cognitive impairment (MCI) [2][3] Group 3: Research Findings - Research involving over 3,000 elderly participants has shown that MCI patients exhibit abnormal frequency bands and network patterns [3] - Non-invasive BCI screening can achieve over 90% sensitivity using just 4 electrodes in a 5-10 minute test, enhancing the efficiency of MCI screening [3] - Non-invasive BCI techniques like transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (TES) are being explored for outpatient rehabilitation of MCI [3] Group 4: Invasive BCI Innovations - Invasive BCI technology has achieved a breakthrough in the surgical treatment of gliomas, marking a significant advancement in neurosurgery [5][6] - The technology allows for real-time analysis of brain signals to differentiate tumor tissue from normal brain tissue, improving tumor resection rates [6] - The first successful application of invasive BCI technology for glioma surgery in China has been reported, showcasing its potential to enhance surgical outcomes [6][7] Group 5: Future Prospects - Invasive BCI technology not only maximizes safe tumor removal but also predicts tumor recurrence, potentially extending patient survival [7] - The industry is awaiting the development of mature products and technologies that could lead to transformative changes in medical practices [7]

Group 1: Technology Developments - Manus has opened registration for its AI agent platform, allowing users to perform one free task daily and offering a one-time bonus of 1000 points [2] - Alipay has launched a new voice call feature, ensuring user privacy and security by not storing call content [2] - Huawei and UBTECH signed a comprehensive cooperation agreement to enhance humanoid robot technology for industrial and home applications [6] Group 2: Market Trends - Reports indicate that Apple may reduce prices for the iPhone 16 series, with the iPhone 16 Pro Max seeing a price drop of approximately 1313.06 RMB [4] - Canalys reported an 8.5% year-on-year increase in global tablet shipments in Q1 2025, reaching 36.8 million units, driven by consumer demand and government subsidies [7] Group 3: Investment Activities - SoftBank's $100 billion investment plan in U.S. AI infrastructure is facing delays due to tariff concerns and economic risks, affecting financing negotiations [5] - Meituan led a multi-million A-round financing for the robotics company Self-Variable, which aims to accelerate the development of intelligent models and robotic applications [8] Group 4: Innovative Products - Shanghai Ladder Medical Technology showcased a brain-computer interface that allows a participant to play video games using thought alone, marking a significant advancement in invasive brain-machine interface technology [9] - Tencent's Hunyuan T1-Vision has launched a feature that enhances image understanding capabilities, improving response and completion times significantly [9]